Get started
Author

Janet Rowan

Observed names: J A. Rowan, J Rowan, J. A. Rowan, J. ROWAN, J. Rowan, J.A. Rowan, JA Rowan, Janet A Rowan, Janet A. ROWAN, Janet A. Rowan, Janet Alison ROWAN, Janet Alison Rowan, Janet ROWAN, Rowan Janet
Observed institutions: University of Auckland, Perth Royal Infirmary, Women's and Children's Hospital, Auckland City Hospital, Christchurch Hospital, Auckland University of Technology, Greenlane Clinical Centre, Immune Tolerance Network, Women's Hospital, Auckland District Health Board, National Heart Foundation of New Zealand, Health New Zealand, The University of Adelaide, University of Otago
ORCID: 0000-0001-8406-3452
Observed ORCID: 0000-0001-8406-3452
OpenAlex ID: A5027611382
Metformin versus Insulin for the Treatment of Gestational Diabetes
2008 · Janet A. Rowan, William M. Hague, et al. · New England Journal of Medicine · 1,330
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
2011 · Janet A. Rowan, Elaine C. Rush, et al. · Diabetes Care · 394
PDF
The detection, investigation and management of hypertension in pregnancy: full consensus statement
2000 · MA Brown, WM Hague, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 372
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
2018 · Janet A Rowan, Elaine C Rush, et al. · BMJ Open Diabetes Research & Care · 321
PDF
An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes
2014 · Ruth C.E. Hughes, M. Peter Moore, et al. · Diabetes Care · 247
The detection, investigation and management of hypertension in pregnancy: executive summary
2000 · MA Brown, WM Hague, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 199
Is There a Role for HbA1c in Pregnancy?
2016 · Ruth C. E. Hughes, Janet Rowan, et al. · Current Diabetes Reports · 113
Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes
2017 · Julie Brown, Ruth Martis, et al. · Cochrane Database of Systematic Reviews · 104
PDF
Metformin Versus Insulin for the Treatment of Gestational Diabetes
2008 · Janet A. Rowan, William M. Hague, et al. · Obstetrical & Gynecological Survey · 102
Metformin for gestational diabetes in routine clinical practice
2011 · J. E. L. Goh, L. Sadler, et al. · Diabetic Medicine · 101
Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?
2006 · R. C. E. Hughes, J. A. Rowan · Diabetic Medicine · 100
Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
2016 · Trecia A Wouldes, Malcolm Battin, et al. · Archives of Disease in Childhood Fetal & Neonatal · 97
Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
2009 · Janet A. Rowan, Wanzhen Gao, et al. · Diabetes Care · 96
PDF
Differing Causes of Pregnancy Loss in Type 1 and Type 2 Diabetes
2007 · Tim Cundy, Greg Gamble, et al. · Diabetes Care · 92
PDF
Metformin Versus Insulin for the Treatment of Gestational Diabetes
2009 · J.A. Rowan, W.M. Hague, et al. · Obstetric Anesthesia Digest · 86
Enoxaparin treatment in women with mechanical heart valves during pregnancy
2001 · Janet A. Rowan, Lesley M.E. McCowan, et al. · American Journal of Obstetrics and Gynecology · 85
Research Gaps in Gestational Diabetes Mellitus
2018 · Deborah J. Wexler, Camille E. Powe, et al. · Obstetrics and Gynecology · 84
Metformin therapy and diabetes in pregnancy
2004 · David Simmons, Barry N J Walters, et al. · The Medical Journal of Australia · 74
Admissions to neonatal intensive care unit following pregnancies complicated by gestational or type 2 diabetes
2003 · Diana Watson, Janet Rowan, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 56
Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes and monitoring
2003 · Janet A Rowan, Claire McLintock, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 54
Response to Comment on Hughes et al. An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes. Diabetes Care 2014;37:2953–2959
2015 · Ruth C.E. Hughes, M. Peter Moore, et al. · Diabetes Care · 53
Maternal and Neonatal Circulating Markers of Metabolic and Cardiovascular Risk in the Metformin in Gestational Diabetes (MiG) Trial
2012 · Helen L. Barrett, Kathryn L. Gatford, et al. · Diabetes Care · 53
PDF
Women with an HbA1c of 41–49 mmol/mol (5.9–6.6%): a higher risk subgroup that may benefit from early pregnancy intervention
2015 · J. A. Rowan, A. Budden, et al. · Diabetic Medicine · 44
Reduced Cortical Excitability, Neuroplasticity, and Salivary Cortisol in 11–13-Year-Old Children Born to Women with Gestational Diabetes Mellitus
2018 · Jago M. Van Dam, Amy J. Garrett, et al. · EBioMedicine · 41
PDF
Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial
2015 · Malcolm R Battin, Victor Obolonkin, et al. · BMC Pediatrics · 41
PDF
Works count: 76
Citation count: 4,935
H-index: 29
I10-index: 48
Year
Topic
Type